AstraZeneca: At first glance, 2013 is ok but 2014 should (again) require downward adjustments

NEUTRAL, Fair Value  3830p (-1%)

News published on February Thursday 6, 2014
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities